期刊文献+

泛素-蛋白酶体途径与疾病 被引量:1

下载PDF
导出
摘要 泛素一蛋白酶体途径(ubiquitin—proteasome pathway,UPP)是一种高效的蛋白分解途径,其生物学作用非常广泛,该途径的异常与诸多疾病如遗传性疾病、炎症、自身免疫性疾病及肿瘤等有密切关系。泛素-蛋白酶体自被发现以来,受到了极大的关注和重视。在2004年,以色列科学家阿龙.切哈诺沃、阿夫拉姆.赫尔什科和美国科学家欧文.罗斯因发现了泛素对蛋白质降解的调节,获得了诺贝尔化学奖。近期已注意到UPP在癌肿治疗中的作用,并已开展了以泛素-蛋白酶体为靶的治疗试验。目前对UPP的研究已经取得了很大的进展。本文就UPP与疾病和治疗的关系进行综述。
出处 《海南医学》 CAS 2007年第3期141-142,152,共3页 Hainan Medical Journal
  • 相关文献

参考文献17

  • 1Susan CS,Katherine SM,Linda H.Monoubiquitin carries a novel internalization sinagal that is appended to activated receptor[J].EMBO J,2000,19 (2):187-198.
  • 2Strickland E,Hakalq K,Thomas PJ,et al.Recognition of misfolding proteins by PA700,the regulatory subcomplex of the 26 S proteasome.J Biol Chem,2000,275 (8),5565-5572.
  • 3Zwickl P.The 20S proteasome Curr Top Microbiol Immunol,2002,268:23 -41.
  • 4Mountz JD.Simgnificance of increased circulating proteaaome in autoimmuine disease.J Rheumatol,2002,29:2045-2052.
  • 5Egerer K,Kuchelkom U,Rudolph P,et al.Circulating proteasomes are marders of cell damage and immunologic activity in autoimmune diseases.J Rheumatol,2002,29:2045-2052.
  • 6Masayuki Kaneko,Yasuyuki Nomura.ER signaling in unfolded protein response.Life Sciences,2003,74:199-25-05.
  • 7王国春,赵孟君,吴东海.强直性脊柱炎患者蛋白酶体基因表达的研究[J].中华风湿病学杂志,2003,7(4):193-197. 被引量:4
  • 8Jury EC,Kabouridis PS,Abba A,et al.Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systenic lupus erythematosus.Arthritis Rheum,2003,48(5):1343-1354.
  • 9Matsushita M,Takasaki Y,Takeuchi K,et al.Autoimmune response to proteasome activator 28alpha in patients with commective tissue diseases.J Rheumatol,2004,31(2):252-259.
  • 10Simon R,Struckmann K,Schraml P.Amp lification pattern of 12q132ql5 genes (MDM2 CDK4,GL I) in urinary bladder cancer[J].Oncogene,2002,21(16):2476-2483.

二级参考文献10

  • 1Niedermann G.Immunological functions of the proteasome[].Current Topics in Microbiology and Immunology.2002
  • 2Fehling H,Swat W,Laplace C,et al.MHC class I expression in mice lacking the proteasome subunit LMP7[].Science.1994
  • 3Driscoll J,Brown M,Finley D,et al.MHC-linked LMP gene products specifically alter peptidase activities of the proteasome[].Nature.1993
  • 4Reidlinger J,Pike AM,Savorfy PJ,et al.Catalytic properties of 26S and 20S proteasomes and radiolabeling of MB1, LMP7 and C7 subunits associated with trypsin-like and chymotrypsin-like activities[].Journal of Biological Chemistry.1997
  • 5Alvarez I,Sesma L,Marcilla M,et al.Identification of novel HLAB27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20S proteasome[].Journal of Biological Chemistry.2001
  • 6Rock KL,Goldberg AL.Degradation of cell proteins and the generation of MHC class I-presented peptides[].Annual Review of Immunology.1999
  • 7Griffin TA,Nandi D,Cruz M,et al.Immunoproteasome assembly:cooperative incorporation of interferon gamma inducible subunit[].The Journal of Experimental Medicine.1998
  • 8Koopmann JO,Hammerling GJ,Momburg F.Generation, intracellular transport and loading of peptides associated with MHC class I molecules[].Current Opinion in Immunology.1997
  • 9Heemels MT,Ploegh H.Generation, translocation and presentation of MHC class I-restricted peptides[].Annual Review of Immunology.1997
  • 10Gaczynska M,Goldberg A,Tanaka K,et al.Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon gamma-induced subunits LMP2 and LMP7[].Journal of Biological Chemistry.1996

共引文献3

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部